« Previous AbstractA Novel Insect Overwintering Strategy: The Case of Mealybugs    Next Abstract"How Glyphosate Impairs Liver Condition in the Field Lizard Podarcis siculus (Rafinesque-Schmaltz, 1810): Histological and Molecular Evidence" »

J Hepatol

Title:		Non-alcoholic steatohepatitis: a non-invasive diagnosis by analysis of exhaled breath
Author(s):		Verdam FJ; Dallinga JW; Driessen A; de Jonge C; Moonen EJ; van Berkel JB; Luijk J; Bouvy ND; Buurman WA; Rensen SS; Greve JW; van Schooten FJ;
Address:		"Department of General Surgery, Nutrition and Toxicology Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands"
Journal Title:		J Hepatol
Year:		2013
Volume:		20121107
Issue:		3
Page Number:		543 - 548
DOI:		10.1016/j.jhep.2012.10.030
ISSN/ISBN:		1600-0641 (Electronic) 0168-8278 (Linking)
Abstract:		"BACKGROUND & AIMS: Histological evaluation of a liver biopsy is the current gold standard to diagnose non-alcoholic steatohepatitis (NASH), but the procedure to obtain biopsies is associated with morbidity and high costs. Hence, only subjects at high risk are biopsied, leading to underestimation of NASH prevalence, and undertreatment. Since analysis of volatile organic compounds in breath has been shown to accurately identify subjects with other chronic inflammatory diseases, we investigated its potential as a non-invasive tool to diagnose NASH. METHODS: Wedge-shaped liver biopsies from 65 subjects (BMI 24.8-64.3 kg/m(2)) were obtained during surgery and histologically evaluated. The profile of volatile organic compounds in pre-operative breath samples was analyzed by gas chromatography-mass spectrometry and related to liver histology scores and plasma parameters of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). RESULTS: Three exhaled compounds were sufficient to distinguish subjects with (n=39) and without NASH (n=26), with an area under the ROC curve of 0.77. The negative and positive predictive values were 82% and 81%. In contrast, elevated ALT levels or increased AST/ALT ratios both showed negative predictive values of 43%, and positive predictive values of 88% and 70%, respectively. The breath test reduced the hypothetical percentage of undiagnosed NASH patients from 67-79% to 10%, and of misdiagnosed subjects from 49-51% to 18%. CONCLUSIONS: Analysis of volatile organic compounds in exhaled air is a promising method to indicate NASH presence and absence. In comparison to plasma transaminase levels, the breath test significantly reduced the percentage of missed NASH patients and the number of unnecessarily biopsied subjects"
Keywords:		Adult Alanine Transaminase/blood Aspartate Aminotransferases/blood *Breath Tests Fatty Liver/*diagnosis/physiopathology Female Humans Liver/pathology Male Middle Aged Non-alcoholic Fatty Liver Disease Volatile Organic Compounds/analysis;
Notes:		"MedlineVerdam, Froukje J Dallinga, Jan W Driessen, Ann de Jonge, Charlotte Moonen, Edwin J C van Berkel, Joep B N Luijk, Jakobus Bouvy, Nicole D Buurman, Wim A Rensen, Sander S Greve, Jan Willem M van Schooten, Frederik Jan eng Research Support, Non-U.S. Gov't Netherlands 2012/11/13 J Hepatol. 2013 Mar; 58(3):543-8. doi: 10.1016/j.jhep.2012.10.030. Epub 2012 Nov 7"